Chimera Investment Corporation (CIM) offers a diversified capital structure focused on residential mortgage loans and agency RMBS. Its fixed-to-floating preferred stocks trade below par with yields between 10.2% and 10.8%, presenting an attractive risk-reward profile compared to baby bonds. Although leverage has increased to 3.3 times, raising risk, CIM maintains a solid credit buffer and stable portfolio fundamentals, making its preferred stocks a compelling option for income-focused investors.
Chimera Investment Corporation's bonds and preferred shares are the subject here, with Pluang providing market context. As of Oct 02, 2026 02:31 WIB, 36 of 85 Financials-sector US stocks on Pluang rose while 48 fell. Notable movers include FUTU at USD 106.58 with a 1-day change of -3.59%, LMND at USD 46.66 up 3.37%, and BCS at USD 23.50 down 3.17%.
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
